Favirpiravir yet to find favour with ICMR

However, the experts were not convinced and decided not to put it in
the revised treatment protocol," a person aware of the matter told ET
on condition of anonymity.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/favirpiravir-yet-to-find-favour-with-icmr/articleshow/76717788.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment